Milligan Sandra bought SYRE
May 27, 2026 · Form 4 insider transaction
Milligan Sandra bought 8,026 shares of Spyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,026
Price
$0.00
Total value
N/A
InsiderMilligan Sandra
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 27, 2026
Filing dateMay 29, 2026
Shares owned after8,026
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase 8,026 shares of the Issuer's common stock, which will vest and become fully exercisable upon the earlier of May 27, 2027 or the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.